Hemizygosity for the COP9 signalosome subunit gene, SGN3, in the Smith-Magenis syndrome.
暂无分享,去创建一个
P. Patel | K. Ferrell | P. Das | W. Dubiel | K. Mykytyn | S. Elsea | K. Coulter | J. Metherall | Pragna Patel | Sarah H. Elsea | Kirk Mykytyn | Katherine Ferrell | Kathryn L. Coulter | Parimal Das | Wolfgang Dubiel | James E. Metherall
[1] J. Lupski,et al. Subunit 3 of the COP9 signal transduction complex is conserved from plants to humans and maps within the smith-magenis syndrome critical region in 17p11.2. , 1999, Genomics.
[2] X. Deng,et al. Making sense of the COP9 signalosome. A regulatory protein complex conserved from Arabidopsis to human. , 1999, Trends in genetics : TIG.
[3] D. Vance,et al. Identification of three novel cDNAs for human phosphatidylethanolamine N-methyltransferase and localization of the human gene on chromosome 17p11.2. , 1999, Biochimica et biophysica acta.
[4] E. Dykens,et al. Distinctiveness and correlates of maladaptive behaviour in children and adolescents with Smith-Magenis syndrome. , 1998, Journal of intellectual disability research : JIDR.
[5] W. Baumeister,et al. A Subcomplex of the Proteasome Regulatory Particle Required for Ubiquitin-Conjugate Degradation and Related to the COP9-Signalosome and eIF3 , 1998, Cell.
[6] Minami Matsui,et al. The COP9 complex is conserved between plants and mammals and is related to the 26S proteasome regulatory complex , 1998, Current Biology.
[7] C. Morton,et al. Association of unconventional myosin MYO15 mutations with human nonsyndromic deafness DFNB3. , 1998, Science.
[8] R. Kraft,et al. A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits , 1998, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[9] J. Lupski,et al. Genetic mapping refines DFNB3 to 17p11.2, suggests multiple alleles of DFNB3, and supports homology to the mouse model shaker-2. , 1998, American journal of human genetics.
[10] F Greenberg,et al. Behavioral phenotype of Smith-Magenis syndrome (del 17p11.2). , 1998, American journal of medical genetics.
[11] F. Greenberg,et al. Sleep disturbance in Smith-Magenis syndrome (del 17 p11.2). , 1998, American journal of medical genetics.
[12] P. Patel,et al. Gene for topoisomerase III maps within the Smith-Magenis syndrome critical region: analysis of cell-cycle distribution and radiation sensitivity. , 1998, American journal of medical genetics.
[13] A. C. Chinault,et al. Homologous recombination of a flanking repeat gene cluster is a mechanism for a common contiguous gene deletion syndrome , 1997, Nature Genetics.
[14] A. Thorburn,et al. MAP kinase‐ and Rho‐dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells , 1997, The EMBO journal.
[15] B. Finucane,et al. Brief Report: Cognitive and Behavioral Profiles in Persons with Smith-Magenis Syndrome , 1997, Journal of autism and developmental disorders.
[16] T. Maniatis,et al. Activation of the IκBα Kinase Complex by MEKK1, a Kinase of the JNK Pathway , 1997, Cell.
[17] P. Patel,et al. Definition of the critical interval for Smith-Magenis syndrome. , 1997, Cytogenetics and cell genetics.
[18] F Greenberg,et al. Molecular analyses of 17p11.2 deletions in 62 Smith-Magenis syndrome patients. , 1996, American journal of human genetics.
[19] C McCluggage,et al. Multi-disciplinary clinical study of Smith-Magenis syndrome (deletion 17p11.2) , 1996, American journal of medical genetics.
[20] H. Li,et al. Role of Multidrug Resistance P-glycoproteins in Cholesterol Biosynthesis (*) , 1996, The Journal of Biological Chemistry.
[21] J. Lupski,et al. The Smith-Magenis syndrome [del(17)p11.2]: Clinical review and molecular advances , 1996 .
[22] Y. Nakamura,et al. The human homologue of the murine Llglh gene (LLGL) maps within the Smith-Magenis syndrome region in 17p11.2. , 1996, Cytogenetics and cell genetics.
[23] Z. Estrov,et al. Molecular and biologic characterization of a newly established Philadelphia-positive acute lymphoblastic leukemia cell line (Z-33) with an autocrine response to GM-CSF. , 1996, Leukemia.
[24] P. Patel,et al. Haploinsufficiency of cytosolic serine hydroxymethyltransferase in the Smith-Magenis syndrome. , 1995, American journal of human genetics.
[25] H. Hobbs,et al. Structure of the human gene encoding sterol regulatory element binding protein-1 (SREBF1) and localization of SREBF1 and SREBF2 to chromosomes 17p11.2 and 22q13. , 1995, Genomics.
[26] L. Shaffer,et al. The human homologue of the Drosophila melanogaster flightless-I gene (flil) maps within the Smith-Magenis microdeletion critical region in 17p11.2. , 1995, American journal of human genetics.
[27] D. Pinkel,et al. Physical mapping of chromosome 17 cosmids by fluorescence in situ hybridization and digital image analysis. , 1994, Genomics.
[28] J C Sanford,et al. Optimizing the biolistic process for different biological applications. , 1993, Methods in enzymology.
[29] D. Ledbetter,et al. Genetic mapping of autosomal dominant Charcot-Marie-Tooth disease in a large French-Acadian kindred: identification of new linked markers on chromosome 17. , 1990, American journal of human genetics.
[30] D. Ledbetter,et al. Precise localization of NF1 to 17q11.2 by balanced translocation. , 1989, American journal of human genetics.